Drug application
IOBENGUANE SULFATE I 131 (IOBENGUANE SULFATE I-131)
Drugs@FDA NDA 020084 · PHARMALUCENCE
Key facts
| Drug name | IOBENGUANE SULFATE I 131 |
|---|---|
| Active ingredients | IOBENGUANE SULFATE I-131 |
| Application type | NDA |
| Application number | 020084 |
| Company | PHARMALUCENCE |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 2.3mCi/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Mar 25, 1994 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.